ABSTRACT
Medicinal Ganoderma mushrooms have long tradition in Asia, and recently they began to be consumed in Europe as well. Among hundreds of Ganoderma species, only a few of them are intensively investigated, i.e., G. lucidum and G. applanatum, whereas the chemistry and bioactivities of the other species, especially of European origin, still remain unknown. This study comprises detailed chemical analysis of two Ganoderma species growing wild in Turkey, G. pfeifferi and G. carnosum. Metal composition of both species shows high concentrations of biogenic metals. Phenolic composition of the isolated extracts of G. carnosum and G. pfeifferi shows that these species are rich in simple phenolic acids, such as 2,5-dihydroxybenzoic acid and vanillic acid, but also in flavonoids. These compounds are found to be carriers of the antioxidant activity but also enzyme inhibition activity of the analyzed extracts. Overall results indicate that these two Ganoderma species have strong potential to be used for medicinal purposes.
Subject(s)
Ganoderma/chemistry , Antioxidants/pharmacology , Enzyme Inhibitors/pharmacology , Flavonoids/chemistry , Ganoderma/classification , Metals/chemistry , Phenols/chemistry , TurkeyABSTRACT
The antioxidant and inhibitory effects of methanol and aqueous extracts from Hymenogaster aromaticus, Ramaria aurea, and Rhizopogon luteolus against cholinesterase, tyrosinase, α-amylase, and α-glucosidase are reported here, to our knowledge for the first time. Antioxidant activities were investigated using different assays, including 2,2-diphenyl-1-picrylhydrazyl, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid), ferric ion-reducing antioxidant power, cupric ion-reducing antioxidant capacity, phosphomolybdenum, and metal-chelating assays. In general, the highest antioxidant and enzyme-inhibitory effects were observed in methanol extracts, which had the highest concentrations of phenolics. (+)-Catechin, benzoic acid, and p-hydroxybenzoic acid were determined to be the main phenolics in H. aromaticus components both in methanol and in aqueous extracts, whereas the other 2 species present very different phenolic fingerprints, also at smaller quantities. These results suggest that these mushroom species may be considered sources of natural agents.
Subject(s)
Agaricales/chemistry , Antioxidants/isolation & purification , Biological Products/isolation & purification , Enzyme Inhibitors/isolation & purification , Antioxidants/chemistry , Biological Products/chemistry , Biological Products/pharmacology , Enzyme Inhibitors/chemistry , TurkeyABSTRACT
This work reports the antioxidant, antimicrobial, and inhibitory effects of methanol and water extracts from Ganoderma applanatum (GAM: methanol extract and GAW: water extract) and G. resinaceum (GRM: methanol extract and GRW: water extract) against cholinesterase, tyrosinase, α-amylase and α-glucosidase. The total phenolics, flavonoids contents, and HPLC profile of phenolic components present in the extracts, were also determined. Antioxidant activities were investigated by using different assays, including DPPH, ABTS, FRAP, CUPRAC, phosphomolybdenum and metal chelating assays. Antimicrobial activity of the tested Ganoderma extracts was also studied by the broth microdilution method. Generally, the highest antioxidant (59.24 mg TEs per g extract for DPPH, 41.32 mg TEs per g extract for ABTS, 41.35 mg TEs per g extract for CUPRAC, 49.68 mg TEs per g extract for FRAP, 130.57 mg AAEs per g extract for phosphomolybdenum and 26.92 mg EDTAEs per g extract) and enzyme inhibitory effects (1.47 mg GALAEs per g extract for AChE, 1.51 mg GALAEs per g extract for BChE, 13.40 mg KAEs per g extract for tyrosinase, 1.13 mmol ACEs per g extract for α-amylase and 2.20 mmol ACEs per g extract for α-glucosidase) were observed in GRM, which had the highest concentrations of phenolics (37.32 mg GAEs g(-1) extract). Again, Ganoderma extracts possess weak antibacterial and antifungal activities. Apigenin and protocatechuic acid were determined as the main components in GRM (1761 µg per g extract) and GAM (165 µg per g extract), respectively. The results suggest that the Ganoderma species may be considered as a candidate for preparing new food supplements and can represent a good model for the development of new drug formulations.
